SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Fannie Lou Hamer — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFannie Lou Hamer
Date of birth1917-10-06
IdentifiersMRN HR-ML031-SYN-TD; SSN (made up) 000-31-2479
Document date1967-05-04
AuthorLorraine Batiste-Hill, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review: blood pressure, kidney function and potassium after the new medicines, lipids, retinal photographs, and benefits. [S]

History of Present Illness

Mrs. Hamer returns six weeks after starting amlodipine-benazepril and dapagliflozin. Her home readings have come down to an average of 138/86. She has had no dizziness, cough, ankle swelling or genital itching. The potassium and creatinine check planned one to two weeks after the new medicines did not happen: the neighbor who was to drive her could not, the health center's van did not run to her road that week, and she did not want to ask again. SNAP has been approved; the energy assistance is pending. She went to the first diabetes class. She agreed today to blood tests and to retinal photographs once the camera was explained, and asked to see the pictures. [S]

ElementDetail
Home blood pressureAverage 138/86
Missed checkPotassium and creatinine not done at one to two weeks: no ride
Side effectsNone
BenefitsSNAP approved; energy assistance pending

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo dizziness or fainting
RespiratoryNegativeNo cough
CardiovascularNegativeNo ankle swelling
GenitourinaryNegativeNo burning or genital itching
EyesPositiveReduced vision in the left eye, unchanged

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin extended-release 500 mg oral tablet, one tablet with the evening meal for one week, then two tablets with the evening mealTwo tablets with the evening meal (after one week of one tablet)Oral route1967-03-09 to 1967-07-13completedS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet dailyOral route1967-03-09activeS
Amlodipine 5 mg and benazepril 20 mg combined oral capsule, one capsule dailyOne capsule dailyOral route1967-03-23activeS
Dapagliflozin 10 mg oral tablet, one tablet daily; stop on days of vomiting, diarrhea or not eating, and before surgeryOne tablet daily, with sick-day rulesOral route1967-03-23activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1967-05-04Body height163cmS
1967-05-04Body weight91.8kgS
1967-05-04Body mass index (BMI) [Ratio]34.6kg/m2S
1967-05-04Systolic blood pressure136mm[Hg]S
1967-05-04Diastolic blood pressure84mm[Hg]S
1967-05-04Heart rate78/minS
1967-05-04Respiratory rate16/minS
1967-05-04Body temperature36.6CelS
1967-05-04Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1967-05-04Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1967-05-04Potassium [Moles/volume] in Serum or Plasma4.7mmol/L3.5-5.1 mmol/LNormalS
1967-05-04Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.59-1.04 mg/dLNormalS
1967-05-04Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1962)/1.73 sq M66mL/min/{1.73_m2}90 or higher is normal; 60 to 89 is mildly decreased (G2)LowS
1967-05-04Cholesterol [Mass/volume] in Serum or Plasma154mg/dL<=199 mg/dLNormalS
1967-05-04Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation80mg/dLGoal below 70 mg/dL with diabetes and kidney diseaseNormalS
1967-05-04Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=50 mg/dLLowS
1967-05-04Triglyceride [Mass/volume] in Serum or Plasma142mg/dL<=149 mg/dLNormalS
1967-05-04Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma26U/L7-35 U/LNormalS

Physical Exam

Vital signs recorded on 1967-05-04; see the Vital Signs section. [S]

SystemFinding
Consent and chaperoneBlood draw, retinal photographs and examination explained and agreed; female nurse present
GeneralWell; blood pressure 136/84, pulse 78; weight 91.8 kg
CardiovascularRegular rhythm; no ankle swelling
EyesRetinal photographs without dilating drops: no diabetic retinopathy in either eye; old scarring in the left eye consistent with her past injury

Problems

ProblemClinical statusVerificationCodeProvenance
Type 2 diabetes with hyperglycemia, newly diagnosed: A1c 8.6% and random glucose 238 mg/dL with thirst and frequent urination; synthetic modern episode linked to the diabetes documented in her later lifeactiveconfirmed E11.65S — Synthetic modern diagnosis; diabetes is documented only at the end of her life.
Elevated blood pressure at intake (164/98 mmHg), without a diagnosis of hypertension; home readings for one week to confirmresolvedconfirmed R03.0S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.
Albumin in the urine (urine albumin-to-creatinine ratio 88 mg/g) and eGFR 73, in a woman whose kidneys were injured in a beating years ago; to be repeated and investigatedresolvedconfirmed R80.9S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks; the old kidney injury is documented.
Hypertension, stage 2, confirmed by home readings (average 152/94 mmHg), with chronic kidney disease; synthetic modern episode linked to the hypertension reported in her later lifeactiveconfirmed I12.9S — Synthetic modern diagnosis; hypertension is reported only at the end of her life.
Chronic kidney disease G2 A2 (eGFR 73, albumin-to-creatinine ratio 88 to 96 mg/g), with a small, scarred right kidney on ultrasound consistent with old injury; diabetes and high blood pressure likely contributeactiveconfirmed N18.2S — Synthetic kidney findings anchored to the documented permanent kidney damage.
Type 2 diabetes with diabetic chronic kidney disease (coded with the kidney disease by convention)activeconfirmed E11.22S — Synthetic modern coding.
Food insecurity: food runs out before the end of most monthsactiveconfirmed Z59.41S — Synthetic social need found on the screen.
Transportation insecurity: no car; the health center is a long drive away and rides are hard to arrangeactiveconfirmed Z59.82S — Synthetic social need anchored to her rural Delta home.
Hyperlipidemia: LDL 146 mg/dLactiveconfirmed E78.5S — Synthetic laboratory finding.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationConsent and chaperone for every examination, test and procedureEvery visitCompleted todayBlood draw, photographs and examination explained and agreed; she asked to see her retinal pictures and they were shown to her
ExaminationClinic blood pressure (seated, two readings, large cuff)Every visitCompleted today136/84
Self-managementHome blood pressure readingsSeven days to confirm the diagnosis; then twice a week, and daily for a week after any changeCompleted todayAverage 138/86
ExaminationWeight and BMIEvery visitCompleted today91.8 kg
LaboratoryPotassium, creatinine and eGFROne to two weeks after starting an ACE inhibitor, then every 6 months (more often with changes)DeferredMissed: the check planned one to two weeks after starting benazepril and dapagliflozin was not done because she had no ride. No harm judging by today's results (potassium 4.7 mmol/L; creatinine 1.04 mg/dL, eGFR 66, a fall of under 10%). Corrective action: checks scheduled on her clinic days with rides booked in advance, and a home blood draw when no ride can be found
LaboratoryLipid panel4 to 12 weeks after starting a statin, then yearlyCompleted todayLDL 80, total cholesterol 154, HDL 46, triglycerides 142 mg/dL
LaboratoryALT, AST and FIB-4At baseline, then yearlyCompleted todayALT 26 U/L on atorvastatin; FIB-4 at intake low (0.82)
ImagingDiabetic eye examination (retinal photographs)At diagnosis, then every 1 to 2 years if no retinopathyCompleted todayNo diabetic retinopathy; old left-eye scarring
Medication safetyMedicine safety: low blood sugar, sick-day rules, genital infections, cough, swelling, adherence and costEvery visitCompleted todayNo dizziness, cough, swelling or genital itching; all medicines affordable through the discount pharmacy
Medication safetyHepatitis B dose 2One month after dose 1Completed todayGiven after she agreed; series complete
Self-managementDiabetes self-management education and supportAt diagnosis, then yearly and when needs changeCompleted todayFirst group class attended
SurveySocial needs screen (AHC-HRSN) and resourcesAt intake, then every few months while needs are openUp to dateSNAP approved; energy assistance pending; transportation the open need

Goal progress:

Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 2 of 2 [S]

Guideline basis: Introduction and Methodology: Standards of Care in Diabetes-2026 (2026); 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026 (2026); 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2026 (2026); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, hypertension, diabetes type 2, hyperlipidemia, chronic kidney disease and depression monographs (2026); Trauma-Informed Care in Behavioral Health Services (Treatment Improvement Protocol 57) (2014); Code of Medical Ethics Opinion 2.1.1: Informed Consent (2026); The Accountable Health Communities Health-Related Social Needs Screening Tool (2017); Adult Immunization Schedule by Age (2026)

Follow-up: Home readings by phone in four weeks. Review in two months with the A1c, urine albumin, potassium and creatinine, the PHQ-9 and the social needs screen, with the ride booked today. Next scheduled visit 1967-07-13: four-month review: A1c, urine albumin, kidney function, mood, social needs, and the metformin dose. [S]